Control of HIV despite the Discontinuation of Antiretroviral Therapy
- 27 May 1999
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 340 (21) , 1683
- https://doi.org/10.1056/nejm199905273402114
Abstract
Eradication of the human immunodeficiency virus (HIV) is a difficult goal to achieve, because a reservoir of replication-competent HIV is established in resting CD4 T lymphocytes soon after infection and persists after years of highly active antiretroviral treatment.1 A more realistic alternative to lifelong cumbersome, toxic, and expensive treatments is to control HIV, as occurs in patients with long-term nonprogression of the disease.Keywords
This publication has 5 references indexed in Scilit:
- HIV-1 suppression by early treatment with hydroxyurea, didanosine, and a protease inhibitorThe Lancet, 1998
- Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of ViremiaScience, 1997
- Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral TherapyScience, 1997
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994
- Long-Term Cultures of HTLV-III—Infected T Cells: a Model of Cytopathology of T-Cell Depletion in AIDSScience, 1986